Ngaba Ngardig Neguemadji

Dr. Ngaba Ngardig Neguemadji

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Rheumatology
Verified
Journal Article
Open access
PDF file
MSManoj Reddy Somagutta
Manoj Reddy Somagutta
NSNishat Shama
Nishat Shama
MPMaria Lourdes Pormento
Maria Lourdes Pormento
RJRavi Pankajbhai Jagani
Ravi Pankajbhai Jagani
NNNgaba Ngardig Neguemadji
Ngaba Ngardig Neguemadji
MJMolly Sanjay Jain
Molly Sanjay Jain
Statins are a class of lipid-lowering medications used worldwide by millions of people and are safe for frequent use in most patients. However, they cause necrotizing autoimmune myopathy in some patients. We reviewed case reports of 80 patients from 2010 to present diagnosed with statin-induced necrotizing autoimmune myopathy (SINAM), aiming to analyze the clinical, physiological, serologic characteristics and outcomes of SINAM. The mean age of these patients was 66 ±9.4, the majority being male (61.3%). All patients reported proximal muscle weakness, and a few had myalgias, extra-muscular symptoms such as dysphagia, and pulmonary complications. Most of the patients were on atorvastatin, simvastatin, or rosuvastatin. The mean creatine kinase was 10,094.2 ±7,351.7 U/l, and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase enzyme was positive for 93.8% of patients. The majority of patients were started on steroids; other treatments were also used. Prompt cessation of statins and initiation of immunosuppressants reduced morbidity and mortality.

1 January 2021 in Infection & Chemotherapy
Verified
Journal Article
Open access
MSManoj Kumar Reddy Somagutta
Manoj Kumar Reddy Somagutta
MPMaria Kezia Lourdes Pormento
Maria Kezia Lourdes Pormento
PHPousette Farouk Hamid
Pousette Farouk Hamid
AHAlaa Hamdan
Alaa Hamdan
MKMuhammad Adnan Khan
Muhammad Adnan Khan
Marcos Sanchez-GonzalezMarcos Sanchez-Gonzalez
Marcos Sanchez-Gonzalez
Somagutta MK, et al. Infect Chemother. 2021 May;53:e26. https://doi.org/10.3947/ic.2021.0016

20 November 2022 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
MSManoj Kumar Reddy Somagutta
Manoj Kumar Reddy Somagutta
UUUtkarsha Uday
Utkarsha Uday
NSNishat Shama
Nishat Shama
NBNarayana Reddy Bathula
Narayana Reddy Bathula
SPSiva Pendyala
Siva Pendyala
NNNgaba Ngardig Neguemadji
Ngaba Ngardig Neguemadji
Background: The use of euglycemic diabetic ketoacidosis (EDKA) related to sodium-glucose cotransporter 2 inhibitors (SGLT2i) use in people with diabetes has been increasingly reported. The causes are multifactorial, and dietary changes in SGLT2i users were observed to trigger EDKA. A ketogenic diet or very low-carbohydrate diet (VLCD) enhances body ketosis by breaking down fats into energy sources, causing EDKA. This study aimed to understand the patient specific risk factors and clinical characteristics of this cohort.Methods: Several databases were carefully analyzed to understand the patients’ symptoms, clinical profile, laboratory results, and safety of dietary changes in SGLT2i’s. Thirteen case reports identifying 14 patients on a ketogenic diet and SGLT2i’s diagnosed with EDKA were reviewed.Results: Of the 14 patients, 12 (85%) presented with type-2 diabetes mellitus (DM) and 2 (15%) presented with type-1 DM. The duration of treatment with SGLT2i before the onset of EDKA varies from 1 to 365 days. The duration of consuming a ketogenic diet or VLCD before EDKA onset varies from 1 to 90 days, with over 90% of patients hospitalized <4 weeks after starting the diet. At presentation, average blood glucose was 167.50±41.80 mg/dL, pH 7.10±0.10, HCO3 8.1±3.0 mmol/L, potassium 4.2±1.1 mEq/L, anion-gap 23.6±3.5 mmol/L, and the average hemoglobin A1c was 10%±2.4%. The length of hospital stay ranged from 1 to 15 days. None of the patients were reinitiated on SGLT2i’s, and 50% (2/4) of the patients reported were on the ketogenic diet or VLCD upon patient questioning.Conclusion: Despite the popularity of the ketogenic diet and VLCD for weight loss, their use in diabetics taking SGLT2i’s is associated with EDKA. Physicians should educate patients with diabetes taking SGLT2i’s about the risk of EDKA. In addition, patients should be encouraged to include their physicians in any decision related to significant changes in diet or exercise routines. Further research is needed to address if SGLT2i’s should be permanently discontinued in patients with diabetes on SGLT2i and whether the ketogenic diet developed EDKA.

12 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
VJVikash Jaiswal
Vikash Jaiswal
MPMaria Kezia Lourdes Pormento
Maria Kezia Lourdes Pormento
NHNamrata Hange
Namrata Hange
NNNgaba Ngardig Neguemadji
Ngaba Ngardig Neguemadji
MSManoj Kumar Somagutta
Manoj Kumar Somagutta
FMFreda Malanyaon
Freda Malanyaon
Background: Dementia, a significant cause of disability and dependency among older adults. The growing population of the elderly in the Philippines is expected to increase the prevalence of dementia in the country. Purpose: This study aims to determine the prevalence of dementia in the elderly population of Barangay Bangkal, Makati City. Methods: Descriptive cross-sectional community-based study was conducted to determine the prevalence of dementia in the elderly population of Barangay Bangkal, Makati City, aged 60 years and above over one month from mid-October to mid-November 2019. Data was collected with help of Mini-Mental State Examination – Philippines version (MMSE-P) to determine the cognitive status and diagnose dementia in elderly population. Results: A total of 266 elderly adults participated in the study. Representatives of the study population were male (59.0%), married (68.0%), with an income of less than 5,000 peso (51.1%), working (64.3%), and with high school education (42.1%). The average age of the study population was 68.02 ( + 6.76) years. The average MMSE score of the participants was 27.05 ( + 3.94). The prevalence of dementia in the sample was 18.8%. Age, income, and level of education were associated with the MMSE score ( r □ = - 0.26, n = 266, p < 0.001, r □ = 0.23, n = 266, p < 0.001, and rs = 0.19, n = 266, p = 0.002, respectively). The findings for statistical significance do resonate with clinical significance as evident during administration of MMSE score. Conclusion: Advancing age increases the risk for cognitive decline while higher income and education level prevent or delays the onset of dementia. Collaborative management between the medical education faculty & students, researchers, and local state health officials might address dementia in the region.

24 June 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
NMNodjimadji Tamlengar Martial
Nodjimadji Tamlengar Martial
NNNgaba Ngardig Neguemadji
Ngaba Ngardig Neguemadji
SPSweetyben Patel
Sweetyben Patel
LMLidya Metekia
Lidya Metekia
IKImteyaz Ahmad Khan
Imteyaz Ahmad Khan
OMOusmane Ahmat Mahamat
Ousmane Ahmat Mahamat
Lower respiratory infections (LRI), upper respiratory infections (URI), and nutritional deficiency (ND) in under-5 children from low-middle-income countries has been at a high level for decades, despite efforts that have been realized in some countries. The study used data extracted from the global burden of diseases (GBD) to analyze the trends behavior between 1990 and 2019, and evaluate their association with maternal factors. Between 1990 and 2019, the incidence of LRI decreased between 1.2 percent and 1.3 percent (1.2-1.3%) in different female age groups, and by nearly 1 to 1.3% in those of the male gender. The incidence of URI did not decrease (0.0%) in any of their age groups. ND incidence declined around 0.7 to 4.9% in the under-5 children. LRI declined mostly in the female age groups (1.2 to 1.3%), while ND decreased more in the male gender (0.9 to 4.9%). Maternal risk factors were strongly associated to the incidence of the three conditions with over 90 percent. Maternal prevalence of HIV/AIDS and tuberculosis positively impacted the incidence of LRI, URI, and ND in Chadian under-5 children. Although the incidence of LRI and ND declined, URI incidence remained steady between 1990 and 2019 in Chadian under-5 children. To improve the health and provide a healthy growth of under-5 children, the maternal prevalence of HIV/AIDS and tuberculosis infection should be strongly addressed for a prompt accomplishment of the sustainable development goals.

1 May 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
NNNgaba Ngardig Neguemadji
Ngaba Ngardig Neguemadji
VLVictoria Lovallo
Victoria Lovallo
AOAnna Oneil
Anna Oneil
XQXegfred Lou T. Quidet
Xegfred Lou T. Quidet
MAMichael Asare
Michael Asare
KMKhaja Misbahuddin
Khaja Misbahuddin
Background: Maturity-onset diabetes of the young (MODY) is a rare monogenic diabetes with significant renal risk, especially when combined with hyperglycemia, obesity, and other factors. While chronic cannabis use may further accelerate kidney decline, no previous reports have described rapid progression to ESRD in a young patient with MODY, obesity, hypertension, and cannabinoid hyperemesis, as presented here. Case presentation: A 24-year-old man with class II obesity, uncontrolled presumed MODY, CKD stage 5, diabetic gastroparesis, hypertension, and chronic marijuana use was diagnosed with MODY at age 18 after hospitalization for cannabinoid hyperemesis and Boerhaave syndrome. Despite insulin and metformin therapy, he experienced recurrent hypertensive crises and AKI with progressive renal decline. Over 70 months, the patient experienced progressive renal and metabolic deterioration. Serum creatinine increased from 0.9 to 10.8 mg/dL (mean 2.92), with eGFR declining from 115.98 to 4.69 mL/min/1.73 m 2 (mean 52.75). Glycemic control was suboptimal (mean HbA1c 9.79%, range 6.5–12.1%). Urine microalbumin increased from 1.2 to 138, and the microalbumin/creatinine ratio increased from 32 to 931. BMI increased from 22.4 to 37.9 kg/m 2 , and toxicology screens were consistently positive for cannabinoids. Insulin aspart was initiated 1 month after presentation. By month 13, enalapril and scheduled prandial insulin were added; the secondary hypertension workup was negative despite suppressing aldosterone and low-normal renin. At month 30, enalapril was replaced with carvedilol and amlodipine, with increased renin but persistently suppressed aldosterone; imaging showed preserved EF, mild pulmonary hypertension, and grade 1 diastolic dysfunction. Hydralazine was added at month 34. By month 70, sitagliptin and sevelamer were initiated for diabetes and hyperphosphatemia (phosphorus 7.7 mg/dL), with persistently suppressed aldosterone (<1) and renin 4.97 ng/mL. Conclusion: This first reported case of presumed MODY, obesity, hypertension, cannabis use, and poor adherence in a young adult demonstrates unusually rapid progression to end-stage renal disease (ESRD), highlighting the need for early recognition and integrated management in high-risk patients.